Large sample inference for a win ratio analysis of a composite outcome based on prioritized components

Biostatistics

Volumn 17, Issue 1, 2016, Pages 178-187

  Bebu, Ionut ^a   Lachin, John M ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Cardiovascular disease; Composite outcomes; Proportion in favor of treatment; U statistic; Win ratio.

Indexed keywords

CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; HUMAN; STATISTICAL MODEL; STATISTICS; CARDIOVASCULAR DISEASES; OUTCOME ASSESSMENT; STATISTICAL ANALYSIS; STATISTICS AND NUMERICAL DATA;

CARDIOVASCULAR DISEASES; DATA INTERPRETATION, STATISTICAL; HUMANS; MODELS, STATISTICAL; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 84959930816     PISSN: 14654644     EISSN: 14684357     Source Type: Journal    
DOI: 10.1093/biostatistics/kxv032     Document Type: Article

References (23)

1. ALOSH, M., BRETZ, F. AND HUQUE, M. (2013). Advanced multiplicity adjustment methods in clinical trials. Statistics in Medicine 33, 693-713.
2. BAKAL, J. A., WESTERHOUT, C. M. AND ARMSTRONG, P.W. (2012). Impact of weighted composite compared to traditional composite outcomes for the design of randomized controlled trials. Statistical Methods in Medical Research. Epub ahead of print, doi: 10.1177/0962280211436004.
3. BAKAL, J. A., ROE, M. T., OHMAN, E.M., GOODMAN, S. G., FOX, K. A. A., ZHENG, Y., WESTERHOUT, C.M., HOCHMAN, J. S., LOKHNYGINA, Y., BROWN, E. B. AND ARMSTRONG, P. W. (2015). Applying novel methods to assess clinical outcomes: insights from the TRILOGY ACS trial. European Heart Journal 36, 385-392.
4. BUYSE, M. (2010). Generalized pairwise comparisons of prioritized outcomes in the two-sample problem. Statistics in Medicine 29, 3245-3257.
5. CIOLINO, J. D. AND CARTER, R. E. (2015). Reanalysis or redefinition of the hypothesis? European Heart Journal 36, 340-341.
6. CLAGGETT, B., WEI, L.-J. AND PFEFFER, M. A. (2013). Moving beyond our comfort zone. European Heart Journal 34, 869-871.
7. DEMIDENKO, A., TAMHANE, A. C. AND WIENS, B. L. (2008). General multistage gatekeeping procedures. Biometrical Journal 50, 667-677.
8. FINE, J. P., JIANG, H. AND CHAPPELL, R. (2001). On semi-competing risks data. Biometrika 88, 907-919.
9. FINKELSTEIN, D. M. AND SCHOENFELD, D. A. (1999). Combining mortality and longitudinalmeasures in clinical trials. Statistics in Medicine 18, 1341-1354.
10. FREEMANTLE, N., CALVERT, M., WOOD, J., EASTAUGH, J. AND GRIFFIN, C. (2003). Composite outcomes in randomized trials: greater precision but with greater uncertainty? The Journal of the American Medical Association 289, 2554-2559.
11. HUQUE, F., ALOSH, M. AND BHORE, R. (2011). Addressing multiplicity issues of a composite outcome and its components in clinical trials. Journal of Biopharmaceutical Statistics 21, 610-634.
12. KHAWAJA, M. Z., WANG, D., POCOCK, S., REDWOOD, S. R. AND THOMAS, M. R. (2014). The percutaneous coronary interventiona prior to transcatherer aortic valve implantation (ACTIVATION) trial: study protocol for a randomized controlled trial. Trial 15, 300.
13. KIRTANE, A. J. AND LEON, M. B. (2012). The placement of aortic transcatheter valve (PARTNER) trial: clinical trialist perspective. Circulation 125, 3229-3232.
14. LACHIN, J. M. (2011) Biostatistical Methods: The Assessment of Relative Risks, 2nd edition. New York: Wiley.
15. LACHIN, J. M. AND BEBU, I. (2015). Application of the Wei-Lachin multivariate one-sided test to multiple event-Time outcomes. Clinical Trials, doi: 10.1177/1740774515601027.
16. LEHMANN, E. L. (1963). Robust estimation in analysis of variance. The Annals ofMathematical Statistics 34, 957-966.
17. LUO, X., TIAN, H., MOHANTY, S. AND TSAI, W. Y. (2015). An alternative approach to confidence interval estimation for the win ratio statistics. Biometrics 71, 139-145.
18. NEATON, J. D., GRAY, G., ZUCKERMAN, B. D. AND KONSTAM, M. A. (2005). Key issues in end point selection for heart failure trials: composite end points. Journal of Cardiac Failure 11, 567-575.
19. POCOCK, S. J. (1997). Clinical trials with multiple outcomes: A statistical perspective on their design, analysis, and interpretation. Controlled Clinical Trials 18, 530-545.
20. POCOCK, S. J., ARITI, C. A., COLLIER, T. J. AND WAND, D. (2012). The win ratio: A new approach to the analysis of composite outcomes in clinical trials based on clinical priorities. European Heart Journal 33, 176-182.
21. RAUCH, G., JAHN-EIMERMACHER, A., BRANNATH, W. AND KIESERA, M. (2014). Opportunities and challenges of combined effect measures based on prioritized outcomes. Statistics in Medicine 33, 1104-1120.
22. THE PEACE TRIAL INVESTIGATORS. (2004). Angiotensin-converting-enzyme inhibition in stable coronary artery disease. The New England Journal of Medicine 351, 2058-2068.
23. WIENS, B. L. AND DEMIDENKO, A. (2005). The fallback procedure for evaluating a single family of hypothesis. Journal of Biopharmaceutical Statistics 15, 929-942.